Recent publications
Article
Kwok, MCK, Oldreive, C, Rawstron, AC, Goel, A, Papatzikas, G, Jones, R, Drennan, S, Agathanggelou, A, Sharma-Oates, A, Evans, P, Smith, E, Dalal, S, Mao, J, Hollows, R, Gordon, N, Hamada, M, Davies, N, Parry, H, Beggs, A, Munir, T, Moreton, P, Paneesha, S, Pratt, G, Taylor, M, Forconi, F, Baird, D, Cazier, J-B, Moss, P, Hillmen, P & Stankovic, T 2020, 'Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL: natural history and mechanism of spontaneous CLL regression', Blood, vol. 135, no. 6, pp. 411-428. https://doi.org/10.1182/blood.2019001262
Parry, HM, Mirajkar, N, Cutmore, N, Zuo, J, Long, H, Kwok, M, Oldrieve, C, Hudson, C, Stankovic, T, Paneesha, S, Kelly, M, Begum, J, McSkeane, T, Pratt, G & Moss, P 2019, 'Long-Term Ibrutinib Therapy Reverses CD8+ T Cell Exhaustion in B Cell Chronic Lymphocytic Leukaemia', Frontiers in immunology, vol. 10, 2832. https://doi.org/10.3389/fimmu.2019.02832
Schuh, AH, Parry-Jones, N, Appleby, N, Bloor, A, Dearden, CE, Fegan, C, Follows, G, Fox, CP, Iyengar, S, Kennedy, B, McCarthy, H, Parry, HM, Patten, P, Pettitt, AR, Ringshausen, I, Walewska, R & Hillmen, P 2018, 'Guideline for the treatment of chronic lymphocytic leukaemia: A British Society for Haematology Guideline', British Journal of Haematology, vol. 182, no. 3, pp. 344-359. https://doi.org/10.1111/bjh.15460
Zuo, J, Willcox, C, Mohammed, F, Davey, M, Hunter, S, Khan, K, Antoun , A, Katakia, P, Croudace, J, Inman, C, Parry, H, Briggs, D, Malladi, R, Willcox, B & Moss, P 2017, 'A disease-linked ULBP6 polymorphism inhibits NKG2D-mediated target cell killing by enhancing the stability of NKG2D ligand binding', Science signaling, vol. 10, no. 481, eaai8904. https://doi.org/10.1126/scisignal.aai8904
Agathanggelou, A, Smith, E, Davies, N, Kwok, M, Zlatanou, A, Oldreive, C, Mao, J, Da Costa, D, Yadollahi, S, Perry, T, Kearns, P, Skowronska, A, Yates, E, Parry, H, Hillmen, P, Reverdy, C, Delansorne, R, Paneesha, S, Pratt, G, Moss, P, Taylor, M, Stewart, G & Stankovic, T 2017, 'USP7 inhibition alters homologous recombination repair and targets CLL cells independent of ATM/p53 functional status', Blood. https://doi.org/10.1182/blood-2016-12-758219, https://doi.org/10.1182/blood-2016-12-758219
Davies, N, Kwok, M, Gould, C, Oldreive, C, Mao, J, Parry, H, Smith, E, Agathanggelou, A, Pratt, G, Taylor, M, Moss, P, Griffiths, M & Stankovic, T 2017, 'Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenografts', OncoTarget, vol. 8, no. 27, pp. 44749-44760. https://doi.org/10.18632/oncotarget.17432
Parry, HM, Stevens, T, Oldreive, C, Zadran, B, Mcskeane, T, Rudzki, Z, Paneesha, S, Chadwick, C, Stankovic, T, Pratt, G, Zuo, J & Moss, P 2016, 'NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma', OncoTarget, vol. 7, pp. 68513-68526. https://doi.org/10.18632/oncotarget.12097
Parry, H, Damery, S, Hudson, C, Maurer, M, Cerhan, J, Pachnio, A, Begum, J, Slager, S, Fegan, C, Man, S, Pepper, C, Shanafelt, T, Pratt, G & Moss, P 2016, 'Cytomegalovirus infection does not impact on survival or time to first treatment in patients with Chronic Lymphocytic Leukaemia', American Journal of Haematology, vol. 91, no. 8, pp. 776–781. https://doi.org/10.1002/ajh.24403
Pratt, G, Thomas, P, Marden, N, Alexander, D, Davis, Z, Hussey, D, Parry, H, Harding, S, Catovsky, D, Begley, J & Oscier, D 2016, 'Evaluation of serum markers in the LRF CLL4 trial: β2-microglobulin but not serum free light chains, is an independent marker of overall survival', Leukemia and Lymphoma, vol. 57, no. 10, pp. 2342-2350. https://doi.org/10.3109/10428194.2015.1137291
Kwok, M, Davies, N, Agathanggelou, A, Smith, E, Oldreive, C, Petermann, E, Stewart, G, Brown, J, Lau, A, Pratt, G, Parry, H, Taylor, M, Moss, P, Hillmen, P & Stankovic, T 2016, 'ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53 or ATM defective chronic lymphocytic leukemia cells', Blood, vol. 127, no. 5, pp. 582-595. https://doi.org/10.1182/blood-2015-05-644872
Parry, HM, Zuo, J, Frumento, G, Mirajkar, N, Inman, C, Edwards, E, Griffiths, M, Pratt, G & Moss, P 2016, 'Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 years', Immunity & Ageing, vol. 13, 1. https://doi.org/10.1186/s12979-015-0056-6
Koczula, KM, Ludwig, C, Hayden, R, Cronin, L, Pratt, G, Parry, H, Tennant, D, Drayson, M, Bunce, CM, Khanim, FL & Günther, UL 2016, 'Metabolic plasticity in CLL: adaptation to the hypoxic niche', Leukemia, vol. 30, no. 1, pp. 65–73. https://doi.org/10.1038/leu.2015.187
Parry, HM, Birtwistle, J, Whitelegg, A, Hudson, C, McSkeane, T, Hazlewood, P, Mudongo, N, Pratt, G, Moss, P, Drayson, MT, Murray, J & Richter, AG 2015, 'Poor functional antibody responses are present in nearly all patients with chronic lymphocytic leukaemia, irrespective of total IgG concentration, and are associated with increased risk of infection', British Journal of Haematology, vol. 171, no. 5. https://doi.org/10.1111/bjh.13455
Oldreive, C, Skowronska, A, Davies, N, Parry, H, Agathanggelou, A, Krysov, S, Packham, G, Rudzki, Z, Cronin, L, Vrzalikova, K, Murray, P, Odintsova, E, Pratt, G, Taylor, M, Moss, P & Stankovic, T 2015, 'T-cell number and subtype influence the disease course of primary chronic lymphocytic leukaemia xenografts in alymphoid mice', Disease Models and Mechanisms, vol. 8, pp. 1401-1412. https://doi.org/10.1242/dmm.021147
Letter
Ludwig, C, Williams, DS, Bartlett, DB, Essex, SJ, McNee, G, Allwood, JW, Jewell, E, Barkhuisen, A, Parry, H, Anandram, S, Nicolson, P, Gardener, C, Seymour, F, Basu, S, Dunn, WB, Moss, PAH, Pratt, G & Tennant, DA 2015, 'Alterations in bone marrow metabolism are an early and consistent feature during the development of MGUS and multiple myeloma', Blood Cancer Journal, vol. 5, e359. https://doi.org/10.1038/bcj.2015.85
View all publications in research portal